Agonist lead identification for the high affinity niacin receptor GPR109a

Bioorganic & Medicinal Chemistry Letters
2007.0

Abstract

A strategy for lead identification of new agonists of GPR109a, starting from known compounds shown to activate the receptor, is described. Early compound triage led to the formulation of a binding hypothesis and eventually to our focus on a series of pyrazole acid derivatives. Further elaboration of these compounds provided a series of 5,5-fused pyrazoles to be used as lead compounds for further optimization.

DOI： 10.1016/j.bmcl.2007.06.028

Knowledge Graph

Similar Paper

Agonist lead identification for the high affinity niacin receptor GPR109a
Bioorganic & Medicinal Chemistry Letters 2007.0
Discovery of pyrazolopyrimidines as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A
Bioorganic & Medicinal Chemistry Letters 2008.0
Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a
Bioorganic & Medicinal Chemistry Letters 2007.0
Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a)
Bioorganic & Medicinal Chemistry Letters 2010.0
GPR109a agonists. Part 2: Pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109a
Bioorganic & Medicinal Chemistry Letters 2010.0
GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole–tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a
Bioorganic & Medicinal Chemistry Letters 2009.0
Discovery of novel pyrrole derivatives as potent agonists for the niacin receptor GPR109A
Bioorganic & Medicinal Chemistry Letters 2020.0
5-N,N-Disubstituted 5-aminopyrazole-3-carboxylic acids are highly potent agonists of GPR109b
Bioorganic & Medicinal Chemistry Letters 2009.0
Discovery of pyrazolyl propionyl cyclohexenamide derivatives as full agonists for the high affinity niacin receptor GPR109A
Bioorganic & Medicinal Chemistry Letters 2010.0
Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109A
Bioorganic & Medicinal Chemistry Letters 2007.0